Stromedix News
Most Popular Stromedix Story
Emerging Drug Developer: Stromedix
Stromedix grooms itself for an M&A deal As the CEO of Cambridge, MA-based Stromedix, a developer headed into a mid-stage trial of its one and only therapy, Mike Gilman has a lot of priorities.
Read more...Latest Headlines
- January 26, 2011
- July 20, 2010
- October 26, 2009
- April 21, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
